Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_116c851e729089df9a427027272fa290 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-605 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-435 |
filingDate |
2016-07-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2020-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_de2ce9a623b4dc379e6425f2ed9d4431 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aa357a46141660028c775b61cbd5565d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4bdce5a88f2fd23d990498ff8f6b7b7f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4305c0b17ebb16bbc2b31c45770aac8e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_42f91635eec447d660044ed59db1053d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9e24ffce11e73f02dba921bb1c6fb723 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4744d44f2028826732a9ccc516c68956 |
publicationDate |
2020-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-3319982-B1 |
titleOfInvention |
New exendin-4 derivatives as selective peptidic dual glp-1 / glucagon receptor agonists |
priorityDate |
2015-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |